AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Joplinglobe

Published October 30, 2026

MycoMeditations Launches “The Bridge” to Connect Psychedelic Therapy with Traditional ...

Read the full story at Joplinglobe

Psychedelic therapy has a continuity-of-care problem. People often pursue treatment outside their existing mental health care, leaving their.

Post on X

Share this story

Surfaced by 2 Google Alerts

Psychedelics
Psychedelic press release